J M Connell

Author PubWeight™ 126.77‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet 1995 4.34
2 Effect of renal-artery stenting on progression of renovascular renal failure. Lancet 1997 3.89
3 Trans-ethnic fine mapping of a quantitative trait locus for circulating angiotensin I-converting enzyme (ACE). Hum Mol Genet 2001 2.75
4 Measured haplotype analysis of the angiotensin-I converting enzyme gene. Hum Mol Genet 1998 2.53
5 Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 2001 1.89
6 Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects. J Clin Endocrinol Metab 1998 1.80
7 Cortisol effects on body mass, blood pressure, and cholesterol in the general population. Hypertension 1999 1.58
8 Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease. Clin Sci (Lond) 2000 1.44
9 Imaging with pentavalent [99mTc]DMSA in patients with medullary cancer of the thyroid. J Nucl Med 1988 1.41
10 Sexual precocity in a 4 year old boy. BMJ 2010 1.39
11 Patient guidance after 131I therapy: time for change? Lancet 1992 1.38
12 The role of laparoscopic adrenalectomy for adrenal tumours of 6 cm or greater. Surg Endosc 2007 1.31
13 Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2. Proc Natl Acad Sci U S A 1992 1.23
14 How reproducible is bilateral forearm plethysmography? Br J Clin Pharmacol 1998 1.21
15 Bronchodilator effect of atrial natriuretic peptide in asthma. BMJ 1989 1.20
16 Self-poisoning with sustained-release aminophylline: secondary rise in serum theophylline concentration after charcoal haemoperfusion. Br Med J (Clin Res Ed) 1982 1.20
17 Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease. Circulation 1996 1.11
18 Expression of 11beta-hydroxylase and aldosterone synthase genes in the rat brain. J Mol Endocrinol 2000 1.09
19 Apparent cortisone reductase deficiency: a functional defect in 11beta-hydroxysteroid dehydrogenase type 1. J Clin Endocrinol Metab 1999 1.06
20 Mistyping of the human angiotensin-converting enzyme gene polymorphism: frequency, causes and possible methods to avoid errors in typing. J Mol Endocrinol 1996 1.03
21 Effects of UK 69 578: a novel atriopeptidase inhibitor. Lancet 1989 1.03
22 Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 1995 1.01
23 Influence of elevated plasma levels of atrial natriuretic factor on bronchial reactivity in asthma. Am Rev Respir Dis 1991 0.99
24 Familial pattern of corticosteroids and their metabolism in adult human subjects--the Scottish Adult Twin Study. J Clin Endocrinol Metab 1999 0.98
25 A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease. J Clin Endocrinol Metab 2005 0.98
26 Peroxidase activity in relation to iodide, 17 beta-oestradiol and thioureylene drug uptake in human polymorphoneutrophils. Biochem Pharmacol 1984 0.98
27 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes. Diabetes 2000 0.98
28 ACE (I/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (enalaprilat) in humans. Circulation 1998 0.96
29 Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension 1999 0.95
30 Candoxatril, a neutral endopeptidase inhibitor: efficacy and tolerability in essential hypertension. J Hypertens 1992 0.94
31 Pregnancy complicated by Cushing's syndrome: potential hazard of metyrapone therapy. Case report. Br J Obstet Gynaecol 1985 0.94
32 Cd36 and molecular mechanisms of insulin resistance in the stroke-prone spontaneously hypertensive rat. Diabetes 2000 0.94
33 Fetal angiotensin II levels and vascular (type I) angiotensin receptors in pregnancies complicated by intrauterine growth retardation. Br J Obstet Gynaecol 1993 0.93
34 Insulin as a vascular hormone: implications for the pathophysiology of cardiovascular disease. Clin Exp Pharmacol Physiol 1998 0.92
35 The effect of estradiol and a combined estradiol/progestagen preparation on insulin sensitivity in healthy postmenopausal women. J Clin Endocrinol Metab 1999 0.90
36 Insulin-mediated vasodilation and glucose uptake are functionally linked in humans. Hypertension 1999 0.90
37 Chronic low-dose infusions of dexamethasone in rats: effects on blood pressure, body weight and plasma atrial natriuretic peptide. J Hypertens 1988 0.89
38 Dexamethasone-suppressible hyperaldosteronism. Adrenal transition cell hyperplasia? Hypertension 1986 0.89
39 The role of plasma osmolality, angiotensin II and dopamine in vasopressin release in man. Clin Endocrinol (Oxf) 1985 0.88
40 Activity of the renin-angiotensin system in acute severe asthma and the effect of angiotensin II on lung function. Thorax 1994 0.88
41 Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease. J Am Coll Cardiol 2001 0.87
42 Angiotensin-converting enzyme gene and diabetes mellitus. Diabet Med 1999 0.86
43 Transient hypothyroidism following radioiodine therapy for thyrotoxicosis. Br J Radiol 1983 0.86
44 Association studies between microsatellite markers within the gene encoding human 11beta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism. J Clin Endocrinol Metab 2002 0.86
45 Co-transfection with protein kinase D confers phorbol-ester-mediated inhibition on glucagon-stimulated cAMP accumulation in COS cells transfected to overexpress glucagon receptors. Biochem J 1997 0.86
46 Corticosteroid production by fetal rat hippocampal neurons. Endocr Res 2000 0.86
47 Insulin action is associated with endothelial function in hypertension and type 2 diabetes. Hypertension 2000 0.86
48 The effect of nebulized albuterol on the activity of the renin-angiotensin system in asthma. Chest 1997 0.85
49 Effect of pretreatment with carbimazole on early outcome following radio-iodine (131I) therapy. Eur J Nucl Med 1984 0.85
50 The long term health consequences of polycystic ovary syndrome. BJOG 2000 0.85
51 Effect of atrial natriuretic factor on bronchomotor tone in the normal human airway. Clin Sci (Lond) 1990 0.85
52 The vasodilating effect of insulin is dependent on local glucose uptake: a double blind, placebo-controlled study. J Clin Endocrinol Metab 1998 0.85
53 Sex hormones induce insulin resistance in 3T3-L1 adipocytes by reducing cellular content of IRS proteins. Diabetologia 2000 0.85
54 Hormones and hypertension. Clin Endocrinol (Oxf) 1989 0.84
55 Glucocorticoid-suppressible hyperaldosteronism: from confusion to conclusion? J Mol Endocrinol 1993 0.84
56 G-proteins in essential hypertension: a study of human platelet plasma membranes. J Hypertens 1993 0.84
57 Long-term use of potassium perchlorate. Postgrad Med J 1981 0.84
58 Pressor and subpressor doses of angiotensin II increase insulin sensitivity in NIDDM. Dissociation of metabolic and blood pressure effects. Diabetes 1994 0.84
59 Hilus cell pathology and hirsutism. Clin Endocrinol (Oxf) 1990 0.84
60 The role of genetic polymorphisms of angiotensin-converting enzyme in the progression of renal diseases. Hypertension 1996 0.84
61 Altered G-protein expression and adenylate cyclase activity in platelets of non-insulin-dependent diabetic (NIDDM) male subjects. Biochim Biophys Acta 1991 0.83
62 Skeletal muscle of stroke-prone spontaneously hypertensive rats exhibits reduced insulin-stimulated glucose transport and elevated levels of caveolin and flotillin. Diabetes 2001 0.83
63 FIRI: a fair insulin resistance index? Lancet 1996 0.82
64 The euglycaemic hyperinsulinaemic clamp: an evaluation of current methodology. Clin Exp Pharmacol Physiol 1997 0.82
65 The atriopeptidase inhibitor UK 69,578 increases atrial natriuretic factor and causes a natriuresis in normal humans. Am J Hypertens 1990 0.82
66 Vascular angiotensin II and atrial natriuretic peptide receptors in normal and growth-retarded human placentae. J Endocrinol 1990 0.81
67 Genetic basis of cardiovascular disease--the renin-angiotensin-aldosterone system as a paradigm. J Renin Angiotensin Aldosterone Syst 2000 0.81
68 Sodium status, corticosteroid metabolism and blood pressure in normal human subjects and in a patient with abnormal salt appetite. Clin Exp Pharmacol Physiol 1996 0.81
69 alpha-adducin and angiotensin I-converting enzyme polymorphisms in essential hypertension. Hypertension 2000 0.81
70 Accumulation of thiourylene antithyroid drugs in mouse salivary gland. J Endocrinol 1983 0.81
71 Guanine nucleotide regulatory protein levels and function in spontaneously hypertensive rat vascular smooth-muscle cells. Biochim Biophys Acta 1992 0.81
72 Pressor responsiveness in steroid-induced hypertension in man. Clin Exp Pharmacol Physiol 1986 0.81
73 Angiotensin-converting enzyme-independent contraction to angiotensin I in human resistance arteries. Circulation 1999 0.81
74 An influence of variation in the aldosterone synthase gene (CYP11B2) on corticosteroid responses to ACTH in normal human subjects. Clin Endocrinol (Oxf) 2001 0.81
75 Insulin resistance and essential hypertension: mechanisms and clinical implications. Am J Med Sci 1994 0.80
76 Insulin vasodilatation and the "arginine paradox". Lancet 1998 0.80
77 Atrial natriuretic peptide in the fetus. BMJ 1989 0.80
78 Isolate housing alters ethanol sensitivity in long-sleep and short-sleep mice. Pharmacol Biochem Behav 1990 0.80
79 Candoxatril, an orally active neutral endopeptidase inhibitor, raises plasma atrial natriuretic factor and is natriuretic in essential hypertension. J Hypertens 1992 0.79
80 Changes in circulating androgens during short term carbamazepine therapy. Br J Clin Pharmacol 1984 0.79
81 The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study. J Clin Endocrinol Metab 2001 0.79
82 Trandolapril does not improve insulin sensitivity in patients with hypertension and type 2 diabetes: a double-blind, placebo-controlled crossover trial. J Clin Endocrinol Metab 2000 0.79
83 Hydrallazine-induced Sjögren's syndrome. Int J Oral Maxillofac Surg 1988 0.79
84 Vasoconstrictor effect of the angiotensin-converting enzyme-resistant, chymase-specific substrate [Pro(11)(D)-Ala(12)] angiotensin I in human dorsal hand veins: in vivo demonstration of non-ace production of angiotensin II in humans. Circulation 2001 0.79
85 Guanine nucleotide regulatory proteins in the spontaneously hypertensive rat. Hypertension 1993 0.79
86 Left ventricular mass in hereditary human hypertension: glucocorticoid-suppressible hyperaldosteronism. J Hypertens 1995 0.78
87 Changes in circulating thyroid hormones during short-term hepatic enzyme induction with carbamazepine. Eur J Clin Pharmacol 1984 0.78
88 The origin and significance of 18-hydroxycortisol: studies in hyperaldosteronism and in bovine adrenocortical cells in vitro. J Steroid Biochem Mol Biol 1991 0.78
89 Potential confounding effect of hand-warming on the measurement of insulin sensitivity. Clin Sci (Lond) 1996 0.78
90 G-proteins in experimental hypertension: a study of spontaneously hypertensive rat myocardial and renal cortical plasma membranes. J Hypertens 1993 0.78
91 The structure and activity of two cytochrome P450c21 proteins encoded in the ovine adrenal cortex. J Biol Chem 1992 0.78
92 Radiological protection guidance for radioactive patients--new data for therapeutic 131I. Nucl Med Commun 1991 0.78
93 Effect of the acyl-CoA:cholesterol acyltransferase inhibitor DuP 128 on cholesterol absorption and serum cholesterol in humans. Clin Pharmacol Ther 1994 0.78
94 Guanine nucleotide regulatory protein alterations in the Milan hypertensive rat strain. J Hypertens 1993 0.77
95 Effects of indomethacin on steroid-induced changes in pressor responsiveness in man. Clin Exp Pharmacol Physiol 1988 0.77
96 Altered 11 beta-hydroxylase activity in glucocorticoid-suppressible hyperaldosteronism. J Clin Endocrinol Metab 1996 0.77
97 Insulin and hypertension. J Hypertens 1994 0.77
98 Renal and hormonal effects of chronic inhibition of neutral endopeptidase (EC 3.4.24.11) in normal man. Clin Sci (Lond) 1993 0.77
99 Circulating plasma concentrations of atrial natriuretic peptide and catecholamines in response to maximal exercise in normal and asthmatic subjects. Thorax 1991 0.77
100 Renal artery stenosis managed by Palmaz stent insertion: technical and clinical outcome. J Hypertens 1995 0.77
101 Effects of dexamethasone on G protein levels and adenylyl cyclase activity in rat vascular smooth muscle cells. J Mol Endocrinol 1992 0.77
102 Glucocorticoid-suppressible hyperaldosteronism: effects of crossover site and parental origin of chimaeric gene on phenotypic expression. Clin Sci (Lond) 1995 0.77
103 Atrial natriuretic peptide: a vasodilator of the fetoplacental circulation? Am J Obstet Gynecol 1991 0.77
104 Congenital adrenal hyperplasia in a Nigerian child with a novel compound heterozygote mutation in CYP11B1. Clin Endocrinol (Oxf) 2007 0.77
105 A comparison of calcium pentagastrin and TRH tests in screening for medullary carcinoma of the thyroid in MEN IIA. Clin Endocrinol (Oxf) 1990 0.77
106 Forearm plethysmography: does the right arm know what the left is doing? Clin Sci (Lond) 2000 0.77
107 Fetal endothelin levels and placental vascular endothelin receptors in intrauterine growth retardation. Obstet Gynecol 1993 0.77
108 Atrial natriuretic hormone: a paracrine or endocrine role within the human placenta? J Clin Endocrinol Metab 1993 0.77
109 Colonic adenocarcinoma associated ectopic ACTH secretion: a case history. Eur J Cancer 1995 0.76
110 Growth hormone, body composition and somatomedin C after treatment of acromegaly. Q J Med 1988 0.76
111 Poor results with technetium-99m (V) DMS and iodine-131 MIBG in the imaging of medullary thyroid carcinoma. J Nucl Med 1986 0.76
112 New genetic concepts in hypertensive cardiovascular disease. Curr Opin Cardiol 1998 0.76
113 Effects of angiotensin II on insulin sensitivity: a placebo-controlled study. Clin Sci (Lond) 1993 0.76
114 Metabolic effects of lacidipine: a placebo-controlled study using the euglycaemic hyperinsulinaemic clamp. Br J Clin Pharmacol 1993 0.76
115 Perioperative haemodynamic changes in patients undergoing laparoscopic adrenalectomy for phaeochromocytomas and other adrenal tumours. Surgeon 2010 0.76
116 Interaction of angiotensin II and atrial natriuretic peptide in the human fetoplacental unit. Am J Hypertens 1990 0.76
117 Seasonal variation in glucocorticoid receptor binding characteristics in human mononuclear leucocytes. Clin Endocrinol (Oxf) 2001 0.76
118 Dopamine effects on adrenocorticotrophin-stimulated aldosterone, cortisol, corticosterone and 11-deoxycorticosteroid concentrations in sodium-replete and sodium-deplete man. J Endocrinol 1986 0.76
119 Effects of 18-hydroxylated steroids on corticosteroid production by human aldosterone synthase and 11beta-hydroxylase. J Clin Endocrinol Metab 2001 0.76
120 Low grade inflammation is notably suppressed by conventional anti-inflammatory treatment: a randomised crossover trial. Heart 2004 0.76
121 Guanine nucleotide regulatory protein alterations in young Milan hypertensive strain rats. Biochim Biophys Acta 1994 0.76
122 Characterization of atrial natriuretic peptide receptors in human fetoplacental vasculature. Am J Physiol 1993 0.76
123 The role of dopamine in the control of corticosteroid secretion and metabolism. J Steroid Biochem 1989 0.76
124 Rapid diagnosis of glucocorticoid suppressible hyperaldosteronism in infants and adolescents. Arch Dis Child 1994 0.75
125 Partial end organ resistance to thyroid hormone in congenital hypothyroidism. Postgrad Med J 1981 0.75
126 Metabolic consequences of salbutamol poisoning reversed by propranolol. Br Med J (Clin Res Ed) 1982 0.75
127 Conn's syndrome: no longer a needle in a haystack? Clin Endocrinol (Oxf) 1998 0.75
128 Hypoparathyroidism and hypocalcaemia during treatment for acute leukaemia. Br Med J (Clin Res Ed) 1982 0.75
129 Do ACE inhibitors improve insulin sensitivity? Lancet 1995 0.75
130 CD36 deficiency and insulin resistance. Lancet 2001 0.75
131 Transluminal vascular stents for ostial atherosclerotic renal artery stenosis. Lancet 1995 0.75
132 Insulin-mediated vasodilation and forearm plethysmography: physiology not pharmacology. Diabetologia 1999 0.75
133 Dose related in vitro effects of ranitidine and cimetidine on basal and ACTH-stimulated steroidogenesis. Gut 1986 0.75
134 Hypertension and non-insulin dependent diabetes. BMJ 1991 0.75
135 Vasodilator response to local hyperinsulinemia. Hypertension 1999 0.75
136 Rapid diagnosis and identification of cross-over sites in patients with glucocorticoid remediable aldosteronism. J Clin Endocrinol Metab 1998 0.75
137 Laparoscopic adrenalectomy. Clin Endocrinol (Oxf) 2001 0.75
138 Endocrine hypertension. J R Coll Physicians Lond 1998 0.75
139 Effect of infused dopamine on free fatty acids in normal females. Horm Metab Res 1989 0.75
140 Specific insulin assays, insulin sensitivity and blood pressure. QJM 1997 0.75
141 Bromocriptine for inappropriate thyrotropin secretion. Ann Intern Med 1982 0.75
142 Angiotensin converting enzyme gene polymorphisms and renal disease. Curr Opin Nephrol Hypertens 1998 0.75
143 Duration of antithyroid action of methimazole estimated with an intravenous perchlorate discharge test. Clin Endocrinol (Oxf) 1987 0.75
144 Not the usual cause of superior vena cava obstruction. Scott Med J 2001 0.75
145 Microsatellite polymorphism analysis allows the individual assignment of the rat 11 beta-hydroxylase gene (Cyp11b1) and the rat aldosterone synthase gene (Cyp11b2) to chromosome 7 using rat x mouse somatic cell hybrids and identifies differences between and within various rat strains. J Mol Endocrinol 1995 0.75
146 The role of glucocorticoid activity in the inheritance of hypertension: studies in the rat. J Steroid Biochem Mol Biol 1993 0.75
147 Inhibition of prolactin secretion by low-dose dopamine infusion in patients with hyperprolactinaemia. Clin Endocrinol (Oxf) 1983 0.75
148 Dopamine effects on 11-deoxycorticosterone concentrations in patients with Cushing's syndrome and in vitro. Clin Endocrinol (Oxf) 1986 0.75
149 Body composition, blood pressure and the renin-angiotensin system in acromegaly before and after treatment. J Hypertens Suppl 1985 0.75
150 Circadian variation of thyrotrophin, determined by ultrasensitive immunoradiometric assay, and the effect of low dose nocturnal dopamine infusion. Clin Sci (Lond) 1987 0.75
151 Structure-function relationships of aldosterone synthase and 11 beta-hydroxylase enzymes: implications for human hypertension. Clin Exp Pharmacol Physiol Suppl 1998 0.75
152 Adrenal corticosteroid synthesis and hypertension. J Hypertens 1991 0.75
153 Neuroendocrine pancreatic cancer: an unusual case of pancreatitis. Scott Med J 2000 0.75
154 Kinetics of [123I]iodide uptake and discharge by perchlorate in studies of inhibition of iodide binding by antithyroid drugs. Acta Endocrinol (Copenh) 1985 0.75
155 Effect of low-dose dopamine infusion on insulin and glucagon release in fasting normal man. Horm Metab Res 1986 0.75
156 Effect of low-dose dopamine infusion on basal and stimulated TSH and prolactin concentrations in man. Clin Endocrinol (Oxf) 1985 0.75
157 Intranasal betamethasone induced acne and adrenal suppression. Br J Dermatol 2000 0.75
158 The effect of low-dose dopamine infusion on anterior pituitary hormone secretion in normal female subjects. Clin Sci (Lond) 1984 0.75
159 ACE gene polymorphism and diabetic complications: is there a connection? BioDrugs 2000 0.75
160 131I-MIBG and medullary carcinoma of the thyroid. Lancet 1984 0.75
161 The role of cortisol in the peripheral granulocyte response to insulin-induced hypoglycaemia in man. Horm Metab Res 1989 0.75
162 Fetal vascular atrial natriuretic peptide receptors in human placenta: alteration in intrauterine growth retardation and preeclampsia. Am J Obstet Gynecol 1994 0.75
163 Association studies, ACE polymorphisms and renal disease. Nephrol Dial Transplant 1996 0.75
164 Clinical response of thyrotropin-secreting macroadenoma to bromocriptine and radiotherapy. Acta Endocrinol (Copenh) 1988 0.75
165 Stimulation of cortisol production in isolated bovine zona fasciculata cells by phorbol ester: role of ion fluxes. J Endocrinol 1988 0.75
166 Neuropeptide Y in multiple endocrine neoplasia: release during surgery for phaeochromocytoma. Clin Endocrinol (Oxf) 1987 0.75
167 Reduced number of angiotensin II receptors on platelets in insulin-dependent diabetes. Clin Sci (Lond) 1986 0.75
168 Maternal and fetal atrial natriuretic peptide levels at delivery from normal and growth retarded pregnancies. Br J Obstet Gynaecol 1992 0.75
169 Harnessing the therapeutic potential of atrial natriuretic peptide. Klin Wochenschr 1989 0.75
170 Effects of the calcium antagonist lacidipine on insulin sensitivity in essential hypertension. A placebo-controlled study. Horm Metab Res 1994 0.75
171 Influence of sodium perchlorate on thiourylene antithyroid drug accumulation in mice. J Endocrinol 1983 0.75
172 Dopamine affects angiotensin II-induced steroidogenesis by altering clearance of the peptide in man. J Endocrinol 1987 0.75
173 Does dopamine regulate aldosterone secretion in the rat? Clin Sci (Lond) 1987 0.75
174 Insulin resistance: possible role in the aetiology and clinical course of hypertension. Clin Sci (Lond) 1992 0.75
175 Polymorphic differences from normal in the aldosterone synthase gene (CYP11B2) in patients with primary hyperaldosteronism and adrenal tumour (Conn's syndrome). Clin Endocrinol (Oxf) 2001 0.75